IVCC will participate at the International Conference on Vector-Borne Diseases (ICVB2025) jointly hosted by the Society for Vector Ecology (SOVE) Indian Region and the Academy of Public Health Entomology (APHE), India. The conference takes place at the Saveetha Institute of Medical and Technical Sciences in Chennai (SIMATS), India from the 21st to 24th January 2025.

IVCC CEO, Justin McBeath, will be giving a keynote address on the topic of ‘Perspectives on insecticide innovation for malaria vector control’. It takes place on Tuesday 21st January at 15:30*.

During the same session, Dr Vasantha Paul John, IVCC’s Registration Consultant, will give an invited talk on ‘Regulatory agility – The need for quick access of vector control tools’.

Other members of the IVCC team will also be in attendance and look forward to contributing insights and progress on expanding the vector control toolbox and the importance of combining tools to achieve malaria elimination.

Please visit the ICVB2025 event website for more information and the full programme.

*Times given in Indian Standard Time.

On 25^th May 2024, Malaria No More UK hosted a reception event alongside the Commonwealth Health Ministers Meeting in Geneva.

The reception brought together Commonwealth health ministers and senior officials, as well as the global malaria community to discuss and shine a light on what is needed to meet the commitments made on ending malaria.

The 2024 Commonwealth Malaria Report was also launched during the event. Produced by Malaria No More UK, African Leaders Malaria Alliance (ALMA) and Asia Pacific Leaders Malaria Alliance (APLMA), the report highlights efforts to end malaria across the Commonwealth. It includes case studies from five countries with a special focus on the Pacific region.

IVCC was proud to participate in the event to make the case for the importance of vector control and showcase our work in the Indo-Pacific, which has recently new grant funding from the Australian Government to support vector control innovation across the region.

IVCC will participate at the International Conference on Vector-Borne Diseases (ICVB2025) jointly hosted by the Society for Vector Ecology (SOVE) Indian Region and the Academy of Public Health Entomology (APHE), India. The conference takes place at the Saveetha Institute of Medical and Technical Sciences in Chennai (SIMATS), India from the 21st to 24th January 2025.

IVCC CEO, Justin McBeath, will be giving a keynote address on the topic of ‘Perspectives on insecticide innovation for malaria vector control’. It takes place on Tuesday 21st January at 15:30*.

During the same session, Dr Vasantha Paul John, IVCC’s Registration Consultant, will give an invited talk on ‘Regulatory agility – The need for quick access of vector control tools’.

Other members of the IVCC team will also be in attendance and look forward to contributing insights and progress on expanding the vector control toolbox and the importance of combining tools to achieve malaria elimination.

Please visit the ICVB2025 event website for more information and the full programme.

*Times given in Indian Standard Time.

IVCC congratulates BASF on the news of the prequalification of Sylando® 240 SC by the World Health Organization (WHO).  This is a welcome new mode of action in the indoor residual spraying (IRS) toolbox. Sylando® 240 SC represents a significant breakthrough, providing a new tool to allow programme managers to rotate between chemistries and be better equipped to manage resistance.

Similar to BASF’s Interceptor® G2 dual insecticide treated nets (ITNs), Sylando® 240 SC formulation contains chlorfenapyr; a potent insecticide for combating mosquitoes for public health.

IVCC supported BASF by providing scientific advice, laboratory support, and supporting rigorous field trials to prove Sylando® 240 SC’s efficacy.

Justin McBeath, Chief Executive Officer at IVCC, said: “Mosquito resistance to current insecticides has been one of the principal reasons for the recent stalling in the gains made since the turn of the century, so we desperately need effective chemistry with modes of action new to public health to combat these resistant mosquitoes, and enable rotation with other products. News that Sylando® 240 SC has recently obtained a WHO PQ listing is therefore very welcome and will prove to be a very valuable part of the vector control toolbox.”

The new BASF Public Health product will be available to protect people from vector-borne diseases such as malaria.

For further information on the WHO Prequalification of Sylando® 240 SC visit: https://extranet.who.int/prequal/vector-control-products/sylando-240-sc

The newly released World Malaria Report, prepared by the World Health Organization (WHO), spotlights a pivotal moment in the fight against malaria. From 2000 to 2023, the global community averted 2.2 billion cases and saved 12.7 million lives—a testament to the power of innovation, collaboration, and commitment to malaria elimination. Yet, with nearly 600,000 lives lost in 2023, predominantly in sub-Saharan Africa, malaria remains a formidable challenge. Fragile health systems, funding gaps, and the compounded effects of climate change and conflict continue to hinder progress toward the WHO’s elimination targets.

Vector control remains central to malaria prevention. In 2023, 78% of the 195 million insecticide-treated nets (ITNs) delivered in sub-Saharan Africa featured next-generation technologies such as pyrethroid-PBO or dual-active ingredients, offering enhanced protection against resistant mosquitoes. While this represents significant progress, only 52% of at-risk populations in the region slept under ITNs in 2023, an improvement from 2015 but still far from the goal of universal coverage. Among young children and pregnant women, coverage was slightly higher at 59%. Over two decades, more than three billion ITNs have been distributed globally, but widespread pyrethroid resistance—now confirmed in 86% of monitored malaria-endemic countries—demands accelerated adoption of these more effective tools.

Encouragingly, countries across regions are making headway, including in the Greater Mekong, where our Indo-Pacific Initiative supports targeted interventions to address regional vector control challenges. These efforts exemplify the transformative impact of scaling innovative solutions alongside strengthening health systems. As the World Malaria Report reminds us, sustained momentum is crucial to closing protection gaps, overcoming resistance, and achieving a malaria-free future.

The “Big Push” initiative represents a timely call to action, uniting global stakeholders to address the persistent challenges in malaria control. By aligning partner support with the specific needs of endemic countries, the initiative emphasizes the importance of bolstering primary healthcare, fostering community engagement, and ensuring the rapid adoption of transformative tools. This coordinated effort, rooted in the Lusaka agenda, underscores the critical need for increased funding, improved data systems, and a whole-of-society approach to reinvigorate progress against malaria.

——-

Each year, the World malaria report serves as a vital tool to assess global progress and gaps in the fight against malaria. This year’s report provides a critical and up-to-date snapshot of efforts to control and eliminate the disease in 83 countries worldwide.

The report also introduces, for the first time, a dedicated chapter emphasizing the need for a more inclusive and effective response, with a focus on reaching the populations most vulnerable to malaria. Groups at high risk of a malaria infection include children under 5, women and girls, Indigenous Peoples, migrants, people with disabilities, and people in remote areas with limited healthcare access.

Download the full report here: https://iris.who.int/bitstream/handle/10665/379751/9789240104440-eng.pdf?sequence=1

More details about the report are available on the WHO website: https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024